Company

Freedom to discover

We are developing a flexible, accessible platform to accelerate single-cell, functional analysis at scale. By consolidating multiple, complex assays into intuitive streamlined workflows we are addressing key limitations in existing methods to provide the freedom to innovate and discover across a broad range of disciplines, from basic and translational research to drug discovery.

Company

Freedom to discover

We are developing a flexible, accessible platform to accelerate single-cell, functional analysis at scale. By consolidating multiple, complex assays into intuitive streamlined workflows we are addressing key limitations in existing methods to provide the freedom to innovate and discover across a broad range of disciplines, from basic and translational research to drug discovery.

Latest News

Meet our team

Leadership team

Our leadership team builds on extensive experience across biology, chemistry, physics, engineering, cell biology, single cell, and genomics.

Paul Loeffen
CEO
Craig Tombling
COO
Paul Steinberg
CCO
Justine Brain
VP Finance
Kathrin Herbst
Director of Science and Business Development
Matthew Wright
Director of Software and Integration
Roger Haley
Director of IP and Legal
Scott Brouilette
Director of Marketing
Simon Margerison
Director of Application Support
Heidi McQueen
Senior Head of People
Tom Isaac
Senior Head of Microfluidic Products

Our advisors

Our advisors

Alex Marson
Director of the UCSF-Gladstone Institute for Genomic Immunology
Professor of Medicine

Alex Marson is Director of the Gladstone-UCSF Institute of Genomic Immunology, and Professor of Medicine at UCSF. Dr. Marson attended college and medical school at Harvard. He received a master’s degree in Biological Sciences from Cambridge University and a PhD in Biology from MIT. Marson was a resident at the Brigham and Women’s Hospital, and completed clinical training in Infectious Diseases at UCSF. He started his lab as a UCSF Sandler Faculty Fellow in 2013. Dr. Marson is the scientific director for Human Health at the Innovative Genomics Institute (IGI). He is a member of the Parker Institute for Cancer Immunotherapy and was selected as one of the inaugural Chan Zuckerberg Biohub investigators. He is also a co-founder of Spotlight Therapeutics and Arsenal Biosciences.

Clare Bryant
University of Cambridge
Professor of Innate Immunity

Our investors

Latest News

We’re hiring. Join the cast!

We are building an amazing team where talented people (like you) can come together to build great things.

Register to receive updates

Be the first to know about product news and events.

Register to receive updates

Be the first to know about product news and events.